B. Metzler Seel. Sohn & Co. Ag Medpace Holdings, Inc. Transaction History

B. Metzler Seel. Sohn & Co. Ag

  • $9.07 Billion
  • Q1 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 9,306 shares of MEDP stock, worth $3.76 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,306
Previous 10,701 13.04%
Holding current value
$3.76 Million
Previous $3.28 Million 14.66%
% of portfolio
0.04%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$284.87 - $413.31 $397,393 - $576,567
-1,395 Reduced 13.04%
9,306 $3.76 Million
Q4 2023

Feb 13, 2024
BUY
$227.52 - $312.68 $83,727 - $115,066
368 Added 3.56%
10,701 $3.28 Million
Q3 2023

Nov 13, 2023
SELL
$233.98 - $281.67 $4.22 Million - $5.08 Million
-18,039 Reduced 63.58%
10,333 $2.5 Million
Q2 2023

Aug 11, 2023
BUY
$187.26 - $240.17 $2.34 Million - $3.01 Million
12,512 Added 78.89%
28,372 $6.81 Million
Q1 2023

May 10, 2023
BUY
$174.31 - $239.52 $83,320 - $114,490
478 Added 3.11%
15,860 $2.98 Million
Q4 2022

Feb 13, 2023
BUY
$153.06 - $226.57 $92,754 - $137,301
606 Added 4.1%
15,382 $3.27 Million
Q3 2022

Nov 14, 2022
BUY
$145.13 - $182.49 $22,059 - $27,738
152 Added 1.04%
14,776 $2.32 Million
Q2 2022

Aug 12, 2022
SELL
$130.2 - $168.03 $213,007 - $274,897
-1,636 Reduced 10.06%
14,624 $2.19 Million
Q1 2022

May 10, 2022
BUY
$138.87 - $214.31 $743,787 - $1.15 Million
5,356 Added 49.12%
16,260 $2.66 Million
Q4 2021

Feb 11, 2022
BUY
$182.74 - $227.9 $1.99 Million - $2.49 Million
10,904 New
10,904 $2.39 Million

Others Institutions Holding MEDP

# of Institutions
622
Shares Held
25.1M
Call Options Held
154K
Put Options Held
117K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.6B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email